Our observations prove that exosomal LINC00265, LINC00467, UCA1, and SNHG1 may act as novel cell-free indicators for AML diagnosis and treatment monitoring and provide a new frontier of liquid biopsy for this type of cancer. The gene discussed is UCA1; the disease is cancer.